What sector does Nath Bio-Genes (I) Ltd belong to?

Nath Bio-Genes (I) Ltd operates in the Fast Moving Consumer Goods sector, specifically the Other Agricultural Products industry, and is listed on the NSE.

What is the current share price of NATHBIOGEN?

As of the latest available quote, NATHBIOGEN traded at ₹147.78. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of NATHBIOGEN?

Nath Bio-Genes (I) Ltd has a price-to-earnings (P/E) ratio of about 6.16. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of NATHBIOGEN?

The market capitalisation of Nath Bio-Genes (I) Ltd is approximately ₹281 Cr.

Is Nath Bio-Genes (I) Ltd profitable?

For its latest reported financial year, Nath Bio-Genes (I) Ltd recorded a net profit margin of about 9.44%.

Does NATHBIOGEN pay a dividend?

Nath Bio-Genes (I) Ltd does not currently show a dividend yield in our data.

What is the return on equity (ROE) of NATHBIOGEN?

Nath Bio-Genes (I) Ltd has a return on equity (ROE) of about 5.47%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of NATHBIOGEN?

Over the past 52 weeks, NATHBIOGEN has traded between a low of ₹126.15 and a high of ₹204.00.

Nath Bio-Genes (I) Ltd

NATHBIOGEN NSE Fast Moving Consumer Goods Other Agricultural Products

₹147.78

-3.10%

Delayed · cached 15 min

Fair value analysis

NATHBIOGEN

Nath Bio-Genes (I) Ltd

₹152.51

Close used for this calculation

₹301.06Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

60/100

Profitability13/25

Returns15/25

Balance Sheet11/25

Efficiency21/25

Growth14/25

Good

Quality radar

Consensus fair value

₹301.06

Below FV

▲ +97.4% against the close used

Model range ₹53.18 – ₹413.00

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹53.18Fair value₹301.06Bull₹413.00

FairClose

52-week traded range

52W low ₹129.0252W high ₹196.01

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Nath Bio-Genes (I) Ltd closed at ₹152.51, 49.3% below the consensus fair value of ₹301.06 drawn from 10 valuation models.

Financial DNA score 60/100 — Good. P/E of 8.3x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹363.95

+138.6%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=5.9%, r=10%, tg=3%, n=10yr

Graham Number

₹383.95

+151.8%

√(22.5 × EPS × BVPS)

EPS=21.91, BVPS=299.04

Graham Formula

₹413.00

+170.8%

EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate

g=5.9%, FD=7%

P/E Fair Value

₹326.46

+114.1%

EPS × 14.9x (sector P/E)

EPS=21.91, Sector P/E=14.9x

Peter Lynch (PEG)

₹129.27

-15.2%

EPS × Growth% (PEG = 1 is fair)

EPS=21.91, g=5.9%

EV/EBITDA

₹318.70

+109.0%

(EBITDA × 13x − Net Debt) ÷ Shares

EBITDA=560M

Dividend Discount (DDM)

₹53.18

-65.1%

D1 ÷ (r − g) where D1 = D0×(1+g)

D0=2.06, r=10%, g=5.9%

Book Value (P/B)

₹163.57

+7.3%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=299.04, ROE=5.5%, g=5.9%, r=10%

Reverse DCF

₹152.51

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: -7.5% | Historical: 5.9%

Margin of Safety

₹278.88

+82.9%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=371.84, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer